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Introduction
Free liquid silicone injections were used for breast
augmentation in the 1950s, 1960s, and beyond [1].
Initially developed in 1962 for the purpose of breast
enlargement, the silicone gel breast implant evolved
to become a principal method of reconstruction after
mastectomy with improvement in reconstructive sur-
gical techniques in the 1970s. Although autogenous
reconstructive techniques such as myocutaneous
flaps have steadily improved during the 1980s and
1990s, a variety of breast implants have remained
the basic method of postmastectomy reconstruction
[2]. Since then, free silicone injections have rarely
been used as a method of breast augmentation.
Ultrasonography (US) is occasionally used to eval-
uate the breasts of patients who have undergone
liquid silicone injections for augmentation, but it 
is not a primary imaging modality because of the
strong acoustic shadows resulting from the silicone
droplets or granulomas [1,3]. Although free silicone
injections into the breast can significantly affect the
ability of US to detect breast masses, lesions that
have developed superficial to the silicone can be
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detected by US. We herein report a patient who
underwent free silicone injection of the breasts 35
years ago, and in whom a small focus of ductal
carcinoma in situ (DCIS) with microcalcifications
was incidentally detected on US.
Case Report
A 53-year-old woman presented with diffuse pal-
pable nodules in both breasts, ranging from about
1.0cm to 3.5cm in greatest dimensions. The nod-
ules had been present for 15 years. On palpation
of the breasts, they were painless and not mobile.
Clinical examination was negative for enlarged
axillary lymph nodes. Trace of her past history
revealed free liquid silicone injections when she
was 18 years old (i.e. 35 years before this presenta-
tion to the breast clinic). Because of the diffuse
nodularity in both breasts and as no particularly
suspicious focal tumor could be felt, breast US and
mammography were requested.
Breast US showed diffuse amorphous hyper-
echoic structures with reverberation artifacts in the
breast stroma, presenting as a “snowstorm” pat-
tern. There were also some cystic structures of var-
ious sizes (0.4–0.8 cm) in the superficial portion of
the breast, while the posterior parenchyma had
lost its definition due to strong attenuation of the
sound beam. All the US findings were attributed to
the overwhelming silicone-induced fibrosis and sil-
icone granulomas. In addition, a small hypoechoic
area containing clustered microcalcifications was
incidentally found in the left breast in the 2 o’clock
direction, 4 cm away from the nipple, and measur-
ing 1.3 ×0.4 cm. The US features were highly sug-
gestive of a DCIS (Fig. 1A). Color Doppler study
showed no evidence of color flow signals in the
nodule (Fig. 1B). US of the axillary region showed
no remarkable enlargement of the lymph node.
US-guided fine needle aspiration was done to
sample the region with clustered microcalcifications,
and the cytologic results showed some malignant
cells. Mammography was done, but only diffuse sili-
cone granulomas were noted in both breasts on the
mediolateral oblique view. No definite tumor was
seen, but clustered microcalcifications were demon-
strated on the craniocaudal view (Fig. 2). Available
management options were discussed with the
patient. Wide local excision of the mass was per-
formed. The tumor inside the resected specimen
measured 1.1 ×0.4 cm and consisted of a circum-
scribed firm nodule. The perimeter of the lesion
was well demarcated and appeared to be encapsu-
lated. Histopathologic examination revealed a DCIS
pattern. At the 20-month postoperative follow-
up, the patient was healthy, with no evidence of
disease recurrence [2].
Discussion
Although liquid silicone injections are no longer 
an accepted method of breast augmentation, the
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iF g. 1. (A) Grayscale ultrasound of the right breast demonstrates a small hypoechoic zone (arrow) in which microcalcifications are
depicted. (B) Color Doppler ultrasound shows no significant color flow signals in the territory of the hypoechoic zone (arrows).
cohort of patients who received silicone injections is
now at the age associated with a high incidence of
breast cancer. However, any breast masses that
develop in these patients are more difficult to detect,
whether by clinical physical examination or by imag-
ing studies. US is one of the major imaging modalities
used to diagnose breast pathologies. Although US is
not recommended for screening, it can yield a diag-
nostic accuracy of 90% for breast carcinomas, even
higher than that yielded by mammography [4].
When US is applied in the evaluation of breasts
with remote free silicone injections, the US beams
are hampered by the various acoustic properties of
silicone and related tissue reactions in the breast.
Strong reflection, refraction, reverberation, and
attenuation of the sound beam by overwhelming
silicone-induced fibrosis and silicone granulomas
lead to diffuse acoustic shadowing, which substan-
tially hinders the capability of US evaluation of the
breasts. Loss of definition of the posterior paren-
chyma is a common sonographic feature of liquid
silicone augmented breasts [1,3,4]. Silicone leak-
age into surrounding tissues can cause three pri-
mary physical interactions with an US beam: (1)
distortions due to changes in the speed of sound;
(2) refraction, causing a “lens” effect; and (3) mul-
tiple scattering, producing the “snowstorm” effect
described previously as a signature pattern for
detection of silicone migration in breast tissue [3].
Although free silicone spread can be identified 
by US, the extent of migration cannot always be
depicted clearly [2].
Silicone gel breast implants may cause local
symptoms, rupture over time, or be associated
with an immunologic reaction such as local granu-
lomatous reaction, silicone-induced mastitis, for-
eign body reaction, fibrosis, silicone migration,
and autoimmune reaction [1,2]. Comprehensive
epidemiologic studies have concluded that there is
no definite connection between breast implants
and the known connective tissue diseases, or
between implants and breast carcinoma [2,5].
There is no increase in the risk of recurrence in
mastectomy patients reconstructed with implants
and no delay in the detection of recurrences [2].
US screening of high familial risk women has
better specificity than magnetic resonance imag-
ing (MRI), albeit with a decrease in sensitivity but at
a fraction of the cost of MRI [6,7]. US has the advan-
tage of providing convenient imaging guidance for
biopsy [4]. Additional MRI can be restricted to prob-
lematic cases in women who have dense breast
parenchyma [8]. In women younger than 40 years,
in whom normal glandular nodularity may be mis-
taken for a dominant mass, US has a role in provid-
ing strong negative reassurance that there is no
real mass but only gland [4,9]. Employing US after
mammography would match MRI in sensitivity,
specificity, positive predictive value, negative pre-
dictive value, and accuracy, and should be used in
these women [8–13]. Combined US and mammo-
graphic assessment has been shown to be very
helpful in identifying benign as well as malignant
lesions causing palpable abnormalities of the breast,
although the sensitivity and specificity may be related
to breast density and age [8–10]. The sensitivity and
specificity of combining US with mammography
are reported to be 100% and 80.1%, respectively,
and the positive and negative predictive values 
are 23.3% and 100%, respectively [8,11–14].
Breast biopsy and MRI may be avoided in women
with palpable abnormalities when both US and
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iF g. 2. Mammography (craniocaudal view, right side) depicts
ymicrocalcifications (arrows) located superficially to the diffusel
distributed silicone granulomas (close-up view).
mammography depict normal tissue at the lump
site, but the patient should be followed-up at short-
term intervals with clinical examination and imaging
[7,11,14]. Combined US and mammography are
therefore commonly used in the assessment of
breast lumps and are now used in some institutions
as a possible screening method in women aged
40–50 years [4,9].
The clinical manifestations of silicone mastopa-
thy are nonspecific. It is difficult to differentiate sil-
icone granulomas from carcinoma clinically because
both may manifest themselves as a palpable mass
[1,3,15]. Identification of focal tumor or carcinoma
of the breast can be hindered by silicone granulo-
mas and associated calcifications. Neither US nor
mammographic studies can reliably exclude super-
imposed carcinoma [1].
Contrast-enhanced fat-suppressed MRI is a use-
ful imaging modality for the evaluation of silicone-
injected breasts and associated liquid silicone
migration, enabling granulomatous disease to be
differentiated from tumor development and meta-
stasis [6,16].
Silicone particles exhibit high signal intensity on
T2-weighted images and inversion recovery images,
but demonstrate intermediate signal intensity on
non-fat-suppressed T1-weighted images, hypointen-
sity on fat-suppressed T1-weighted images, and
do not exhibit definite enhancement. In patients
who have had liquid silicone injections, lesions
exhibit low signal on T2-weighted images and fat-
suppressed T1-weighted images. This difference
may be the result of two factors. First, the liquid 
silicone may have contained adulterated materials,
such as some kind of oil, leading to the unusual
signal characteristics on MRI. Second, the breasts
may have sustained a long period of chronic granu-
lomatous reaction resulting in fibrosis and formation
of multiple silicone granulomas with or without cal-
cifications, potentially causing the low signal seen
on the T2-weighted images [15,17].
Free silicone injection of the breast may make US
detection of breast mass difficult, but any mass su-
perficial to the silicone granulomas can be depicted
by US without being hampered by the silicone. 
In our patient, the presence of clustered microcal-
cifications in a small area of hypoechogenicity was
highly suggestive of DCIS on US, and the histo-
logic diagnosis was conclusive after US-guided
biopsy.
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